Molecular Partners AG (MOLN)
4.25
+0.48
(+12.88%)
USD |
NASDAQ |
May 03, 13:33
Molecular Partners Total Liabilities (Quarterly): 26.10M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 26.10M |
| September 30, 2023 | 23.95M |
| June 30, 2023 | 27.26M |
| March 31, 2023 | 24.49M |
| December 31, 2022 | 29.22M |
| September 30, 2022 | 30.49M |
| June 30, 2022 | 35.02M |
| March 31, 2022 | 51.28M |
| December 31, 2021 | 71.52M |
| September 30, 2021 | 55.58M |
| June 30, 2021 | 78.56M |
| December 31, 2020 | 91.94M |
| June 30, 2020 | 44.50M |
| December 31, 2019 | 52.43M |
| June 30, 2019 | 58.16M |
| Date | Value |
|---|---|
| June 30, 2019 | 58.16M |
| December 31, 2018 | 64.45M |
| June 30, 2018 | 11.12M |
| June 30, 2018 | 11.12M |
| December 31, 2017 | 28.43M |
| June 30, 2017 | 44.75M |
| June 30, 2017 | 44.75M |
| December 31, 2016 | 47.47M |
| June 30, 2016 | 60.41M |
| June 30, 2016 | 60.41M |
| December 31, 2015 | 68.39M |
| June 30, 2015 | 54.56M |
| June 30, 2015 | 54.56M |
| December 31, 2014 | 46.05M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
23.95M
Minimum
Sep 2023
91.94M
Maximum
Dec 2020
47.42M
Average
47.89M
Median
Total Liabilities (Quarterly) Benchmarks
| AC Immune SA | 26.40M |
| CRISPR Therapeutics AG | 346.77M |
| Addex Therapeutics Ltd | 4.163M |
| NLS Pharmaceutics Ltd | 6.557M |
| MoonLake Immunotherapeutics | 13.05M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 236.15M |
| Shareholders Equity (Quarterly) | 210.05M |
| Current Ratio | 13.35 |